← FDA Drug Approvals (Drugs@FDA)

CLADRIBINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2004-04-22

Drug application

FDA Application #

ANDA076571

Application type

Abbreviated New Drug Application (Generic)

Brand name

CLADRIBINE

Generic name

CLADRIBINE

Active ingredients

CLADRIBINE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

Manufacturer

Fresenius Kabi USA, LLC

First approval

2004-04-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown